Age-related changes in dorsal root ganglia, circulating and vascular calcitonin gene-related peptide (CGRP) concentrations in female rats: Effect of female sex steroid hormones

Neuroscience Letters

Volumn 454, Issue 2, 2009, Pages 118-123

  Gangula, Pandu R R ^a   Chauhan, Madhu ^b   Reed, Luckey ^b   Yallampalli, Chandra ^b  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Aging; CGRP; Circulation; Dorsal root ganglia; Estrogen; Progesterone; Vasculature; Young adult

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR LIKE RECEPTOR; ESTRADIOL; PLACEBO; PROGESTERONE; RECEPTOR ACTIVITY MODIFYING PROTEIN 1;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; MESENTERIC ARTERY; NONHUMAN; OVARIECTOMY; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RAT; SMOOTH MUSCLE FIBER; SPINAL GANGLION; VASCULAR ENDOTHELIUM; VASCULARIZATION; WESTERN BLOTTING;

AGING; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; GANGLIA, SPINAL; HORMONES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MESENTERIC ARTERIES; MYOCYTES, SMOOTH MUSCLE; OVARIECTOMY; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITONIN;

EID: 62949153655     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.02.068     Document Type: Article

References (54)

1. Bergman E., Johnson H., Zhang X., Hokfelt T., and Ulfhake B. Neuropeptides and neurotrophin receptor mRNAs in primary sensory neurons of aged rats. J. Comp. Neurol. 375 (1996) 303-319
2. Blough E.R., Rice K.M., Desai D.H., Wehner P., and Wright G.L. Aging alters mechanical and contractile properties of the Fisher 344/Nnia X Norway/Binia rat aorta. Biogerontology 8 (2007) 303-313
3. Brain S.D., Williams T.J., Tippins H.R., Morris J.R., and MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature 313 (1985) 54-56
4. Chauhan M., Gangula P.R., Wimalawansa S.J., and Yallampalli C. Studies on the effects of the N-terminal domain antibodies of calcitonin receptor-like receptor and receptor activity-modifying protein 1 on calcitonin gene-related peptide induced vasorelaxation in rat uterine artery. Biol. Reprod. 70 (2004) 1658-1663
5. Clark L.T. Issues in minority health: atherosclerosis and coronary heart disease in African Americans. Med. Clin. North Am. 89 (2005) 977-1001
6. Clark L.T., and Atat F.E. Metabolic syndrome in African Americans: implications for preventing coronary heart disease. Clin. Cardiol. 30 (2007) 161-164
7. Clark L.T., Ferdinand K.C., Flack J.M., Gavin III J.R., Hall W.D., Kumanyika S.K., Reed J.W., Saunders E., Valantine H.A., Watson K., Wenger N.K., and Wright J.T. Coronary heart disease in African Americans. Heart Dis. 3 (2001) 97-108
8. Dong Y.L., Vegiraju S., Chauhan M., Gangula P.R., Hankins G.D., Goodrum L., and Yallampalli C. Involvement of calcitonin gene-related peptide in control of human fetoplacental vascular tone. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H230-H239
9. Dubey R.K., Imthurn B., Barton M., and Jackson E.K. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc. Res. 66 (2005) 295-306
10. Dubey R.K., Oparil S., Imthurn B., and Jackson E.K. Sex hormones and hypertension. Cardiovasc. Res. 53 (2002) 688-708
11. Farhat M.Y., Laving M.C., and Ram well P.W. The vascular protective effects of estrogen. FASEB J. 10 (1996) 615-624
12. Fausett M.B., Belfort M.A., Nanda R., Saade G.R., and Vedernikov Y.P. The effects of sex steroids on human umbilical artery and vein. J. Soc. Gynecol. Invest. 6 (1999) 27-31
13. Gangula P.R., Lanlua P., Bukoski R.D., Wimalawansa S.J., and Yallampalli C. Mesenteric arterial relaxation to calcitonin gene-related peptide is increased during pregnancy and by sex steroid hormones. Biol. Reprod. 71 (2004) 1739-1745
14. Gangula P.R., Wimalawansa S.J., and Yallampalli C. Pregnancy and sex steroid hormones enhance circulating calcitonin gene-related peptide levels in rats. Hum. Reprod. 15 (2000) 949-953
15. Gangula P.R.R., Lanlua P., Wimalawansa S.J., Supowit S.C., DiPette D.J., and Yallampalli C. Regulation of calcitonin gene-related peptide expression in dorsal root ganglia of rats by female sex steroid hormones. Biol. Reprod. 62 (2000) 1033-1039
16. Gangula P.R.R., Wimalawansa S.J., and Yallampalli C. Progesterone upregulates vasodilator effects of calcitonin gene-related peptide in NG-nitro-l-arginine methyl ester-induced hypertension. Am. J. Obstet. Gynecol. 176 (1997) 894-900
17. Gangula P.R.R., Wimalawansa S.J., and Yallampalli C. Sex steroid hormones enhance hypotensive effects of calcitonin gene-related peptide in aged female rats. Biol. Reprod. 67 (2002) 1881-1887
18. Gangula P.R.R., Zhao H., Wimalawansa S.J., Supowit S.C., DiPette D.J., and Yallampalli C. Pregnancy and steroid hormones enhance the systemic and regional hemodynamic effects of calcitonin gene-related peptide (CGRP) in rats. Biol. Reprod. 64 (2001) 1776-1783
19. Guo X., Razandi M., Pedram A., Kassab G., and Levin E.R. Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. J. Biol. Chem. 280 (2005) 19704-19710
20. Gupta S., Mehrotra S., Villalon C., De V.R., Garrelds I., Saxena P., and Vandenbrink A.M. Effects of female sex hormones on responses to CGRP, acetylcholine, and 5-HT in rat isolated arteries. Headache 47 (2007) 564-575
21. Holman J.J., Craig R.K., and Marshall I. Human alpha- and beta-CGRP and rat alpha-CGRP are coronary vasodilators in the rat. Peptides 7 (1986) 231-235
22. Ichikawa A., Sumino H., Ogawa T., Ichikawa S., and Nitta K. Effects of long-term transdermal hormone replacement therapy on the rennin-angiotensin-aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women. Geriatr. Gerontol. Int. 8 (2008) 259-264
23. Koledova V.V., and Khalil R.A. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease. Expert Rev. Cardiovasc. Ther. 5 (2007) 777-789
24. Lamon-Fava S., Barnett J.B., Woods M.N., McCormack C., McNamara J.R., Schaefer E.J., Longcope C., Rosner B., and Gorbach S.L. Differences in serum sex hormone and plasma lipid levels in Caucasian and African-American premenopausal women. J. Clin. Endocrinol. Metab. 90 (2005) 4516-4520
25. Li Y. Effect of age on vascular content of calcitonin gene-related peptide and mesenteric vasodilator nerve activity in the rat. Eur. J. Pharmacol. 236 (1993) 373-378
26. Lobo R.A., Bélisle S., Creasman W.T., Frankel N.R., Goodman N.F., Hall J.E., Ivey S.L., Kingsberg S., Langer R., Lehman R., McArthur D.B., Montgomery-Rice V., Notelovitz M., Packin G.S., Rebar R.W., Rousseau M., Schenken R.S., Schneider D.L., Sherif K., and Wysocki S. Should symptomatic menopausal women be offered hormone therapy?. Med Gen. Med. 8 (2006) 40
27. Lokkeggard E., Andreasen A.H., Jacobsen R.K., Nielsen L.H., Agger C., and Liddegard O. Hormone therapy and risk of myocardial infarction: a national register study. Eur. Heart J. 29 (2008) 2660-2668
28. Lu J.K., LaPolt P.S., Nass T.E., Matt D.W., and Judd H.L. Relation of circulating estradiol and progesterone to gonadotropin secretion and estrous cyclicity in aging female rats. Endocrinology 116 (1985) 1953-1959
29. Manson J.M., Sammel M.D., Freeman E.W., and Grisso J.A. Racial differences in sex hormone levels in women approaching the transition to menopause. Fertil. Steril. 75 (2001) 297-304
30. Maria N.C., Stefan A.C., Karin S.G., and Karolina K. Acute dilatation to phytoestrogens and estrogen receptor subtypes expression in small arteries from women with coronary heart disease. Atherosclerosis 196 (2008) 49-58
31. Marti E., Gibson S.J., Polak M.N., Facer P., Springall D.R., Aswegen G., Aitchison M., and Koltzenburg M. Ontogeny of peptide and amino-containing neurons in motor, sensory and autonomic regions of rat and human spinal cord, dorsal root ganglia and rat skin. J. Comp. Neurol. 266 (1987) 332-359
32. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., and Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393 393 (1998) 333-339
33. Miller S.R., Gallicchio L.M., Lewis L.M., Babus J.K., Langenberg P., Zacur H.A., and Flaws J.A. Association between race and hot flashes in midlife women. Maturitas 54 (2006) 260-269
34. Miyauchi T., Tomobe Y., Ishikawa T., Goto K., and Sugishita Y. Calcitonin gene-related peptide (CGRP) induces more potent vasorelaxation in the resistance portion than in the conduit portion of mesenteric arteries in humans. Peptides 17 (1996) 877-879
35. Montgomery Rice V. Hormone replacement therapy: optimizing the dose and route of administration. Drugs Aging 19 (2002) 807-817
36. Nechmad A., Merin G., Schwalb H., Shimon D.V., Borman J.B., Milgalter E., and Mosseri M. Estrogen induces nitric oxide-mediated vasodilation of human mammary arteries in vitro. Nitric Oxide 2 (1998) 460-466
37. Nelson H.D., Humphrey L.L., Nygren P., Teutsch S.M., and Allan J.D. Postmenopausal hormone replacement therapy: scientific review. J. Am. Med. Assoc. 288 (2002) 872-881
38. Neves-E-Castro, Samsioe G., Doren M., and Skouby O. Results from WHI and HERS II-implications for women and the prescriber of HRT. Maturitas 42 (2002) 255-258
39. Nevo O., Soustiel J.F., and Thaler I. Cerebral blood flow is increased during controlled ovarian stimulation. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H3265-H3269
40. Post M.S., Verhoeven M.O., van der Mooren M.J., Kenemans P., Stehouwer C.D., and Teerlink T. Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women. J. Clin. Endocrinol. Metab. 88 (2003) 4221-4226
41. Qiao X., Kristi R., McConnell B.S., and Khalil R.A. Sex steroids and vascular responses in hypertension and aging. Gend. Med. 5 (2008) S46-S64
42. Spinetti A., Margutti A., Bertolloni S., Bernardi F., BiFulco G., Uberti E.C., Petraglia F., and Genazzani A.R. Hormonal replacement therapy affects calcitonin gene-related peptide and atrial natriuretic peptide secretion in postmenopausal women. Eur. J. Endocrinol. 137 (1997) 664-669
43. Stice J.P., Eiserich J.P., and Knowlton A.A. Role of aging versus the loss of estrogens in the reduction in vascular function in female rats. Endocrinology 150 (2009) 212-219
44. Stonier C., Bennett J., Messenger E.A., and Aber G.M. Oestradiol-induced hypotension in spontaneously hypertensive rats: putative role for intracellular cations, sodium-potassium flux and prostanoids. Clin. Sci. 82 (1992) 389-395
45. Unemoto T., Honda H., and Kogo H. Differences in the mechanisms for relaxation of aorta induced by 17beta-estradiol or progesterone between normotensive and hypertensive rats. Eur. J. Pharmacol. 472 (2003) 119-126
46. Valentini A., Petraglia F., De Vita D., Nappi C., Margutti A., degli Uberti E.C., and Genazzani A.R. Changes of plasma calcitonin gene-related peptide levels in postmenopausal women. Am. J. Obstet. Gynecol. 175 (1996) 638-642
47. van Rossum D., Hanisch U.K., and Quirion R. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci. Biobehav. Rev. 21 (1997) 649-678
48. Vera R., Sánchez M., Galisteo M., Villar I.C., Jimenez R., Zarzuelo A., Pérez-Vizcaíno F., and Duarte J. Chronic administration of genistein improves endothelial dysfunction in spontaneously hyperactive rats: involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity. Clin. Sci. 112 (2007) 183-191
49. Welton A.J., Vickers M.R., Kim J., Ford D., Lawton B.A., MacLennan A.H., Meredith S.K., Martin J., Meade T.W., and for the WISDOM Team. Health related quality of life after combined hormone replacement therapy: randomised controlled trial. Br. Med. J 337 (2008) a1190 10.1136/bmj.a1190
50. Wierman M.E., and Kohrt W.M. Vascular and metabolic effects of sex steroids: new insights into clinical trials. Reprod. Sci. 14 (2007) 300-314
51. Wimalawansa S.J. Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology and therapeutic potentials. Endocr. Rev. 17 (1996) 533-585
52. Wimalawansa S.J., and El-Kholy A.A. Comparative study of distribution and biochemical characterization of brain calcitonin gene-related peptide receptors in five different species. Neuroscience 54 (1993) 513-519
53. Xu X., Xiao J.C., Luo L.F., Wang S., Zhang J.P., Huang J.J., Liu M.L., Liu C.G., Xu K.Q., Li Y.J., and Song H.P. Effects of ovariectomy and 17beta-estradiol treatment on the renin-angiotensin system, blood pressure, and endothelial ultrastructure. Int. J. Cardiol. 130 (2007) 196-204
54. Yallampalli C., Kondapaka S.B., Lanlua P., Wimalawansa S.J., and Gangula P.R. Female sex steroid hormones and pregnancy regulate receptors for calcitonin gene-related peptide in rat mesenteric arteries, but not in aorta. Biol. Reprod. 70 (2004) 1055-1062